Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: Five-year results

Journal of Clinical Oncology

Volumn 14, Issue 8, 1996, Pages 2331-2336

  Laccourreye, O ^a   Brasnu, D ^a   Bassot, V ^a   Menard M ^a   Khayat, D ^a   Laccourreye, H ^a  

^a Hopital Laennec   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; GASTROINTESTINAL TOXICITY; GLOTTIS; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND CANCER; SQUAMOUS CELL CARCINOMA;

EID: 0029788803     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.8.2331     Document Type: Article

References (40)

1. Harwood AR, Hawkins NV, Rider WD, et al: Radiotherapy of early glottic cancer. Int J Radiat Oncol Biol Phys 5:477-482, 1979
2. Harwood AR, Hawkins NV, Keane T, et al: Radiotherapy of early glottic cancer. Laryngoscope 90:465-470, 1980
3. Wagenfield SHJ, Harwood AR, Bryce DP, et al: Second primary respiratory tract malignancies in glottic carcinoma. Cancer 46:1883-1886, 1980
4. Mittal B, Rao DV, Marks JE, et al: Role of radiation in the management of early vocal cord carcinoma. Int J Radiat Oncol Biol Phys 9:997-1002, 1983
5. Karim ABMF, Snow GB, Siek HTH, et al: The quality of voice in patients irradiated for laryngeal carcinoma. Cancer 51:47-49, 1983
6. Chacko DC, Hendrickson F, Fisher A: Definite irradiation of T1-T4NO larynx cancer. Cancer 51:994-1000, 1983
7. Amornmarn R, Prempree T, Viravathana T, et al: A therapeutic approach to early vocal cord carcinoma. Acta Radiol Oncol 24:321-325, 1985
8. Sinha PP: Radiation therapy in early carcinoma of the true vocal cords (stage I and II). Int J Radiat Oncol Biol Phys 13:1635-1640, 1987
9. Howell-Burke D, Peters LJ, Goepfert H, et al: T2 glottic cancer recurrence, salvage, and survival after definite radiotherapy. Arch Otolaryngol Head Neck Surg 116:830-835, 1990
10. Roberts TJ, Epstein B, Lee DJ: Second neoplasms in patients with carcinoma of the vocal cord: Incidence and implications for survival. Int J Radiat Oncol Biol Phys 21:583-589, 1991
11. Viani E, Stell PM, Dalby JE: Recurrence after radiotherapy for glottic carcinoma. Cancer 67:577-584, 1991
12. Laccourreye O, Weinstein GS, Bassot V, et al: A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2. Cancer 74:2781-2790, 1994
13. Laccourreye O, Bassot V, Naudo PH, et al: Chimiothérapie cisplatine-fluorouracile dans les cancers à point de départ glottique classés T2. Ann Otolaryngol Chir Cervicofac 111:281-291, 1994
14. Laccourreye O, Salzer SJ, Brasnu D, et al: Glottic carcinoma with a fixed true vocal cord - Outcomes following neoadjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Otolaryngol Head Neck Surg 114:400-406, 1996
15. Laccourreye O, Bassot V, Brasnu D, et al: Chimiothérapie exclusive dans les cancers de la corde vocale T1-T3NO en réponse clinique complète après chimiothérapie néo-adjuvante. Nouv Presse Med 24:1337-1340, 1995
16. Beahrs OH, Henson DE, Mutter RVP, et al (eds): American Joint Committee on Cancer (ed 3). Philadelphia. PA, Lippincott. 1988, pp 39-44
17. Amrein PC, Weitzman SA: Treatment of squamous cell carcinoma of the head and neck with cisplatin and 5-fluorouracil. J Clin Oncol 3:1632-1639, 1985
18. Brasnu D, Laccourreye O, Chabardes E, et al: Chirurgie conservatrice du larynx comme alternative à la laryngectomie totale après chimiothérapie néo-adjuvante. Ann Otolaryngol Chir Cervicofac 110:129-133, 1993
19. Brasnu D, Laccourreye O, Chabardes E, et al: Laryngeal preservation following neoadjuvant chemotherapy, a preliminary study, in Johnson JT, Didolkar MS (eds): Head and Neck Cancer (vol 3). Amsterdam, the Netherlands, Excerpta Medica, 1993, pp 299-306
20. Laccourreye H, Bonfils P, Brasnu D, et al: Chimiothérapie et chirurgie partielle dans les épithéliomas du pharyngo-larynx. Ann Otolaryngol Chir Cervicofac 105:409-414, 1988
21. Laccourreye H, Brasnu D, Lacau St Guily J, et al: High response rate after induction chemotherapy in stage III head and neck cancer. Proc Am Soc Clin Oncol 25:187, 1984 (abstr)
22. Lacau St Guily J, Brasnu D, Bassot V, et al: Chimiothérapie d'induction des cancers des voies aéro-digestives supérieures. Analyse de la réponse tumorale chez 176 malades. Nouv Presse Med 14:1313-1316, 1985
23. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
25. Jacobs C, Goffinet DR, Goffinet L, et al: Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 60:1178-1183, 1987
26. Thyss A, Schneider M, Santini J, et al: Induction chemotherapy with cisplatinium and 5FU for squamous cell carcinoma of the head and neck. Br J Cancer 54:755-760, 1986
27. Jacobs JR, Pajak TF, Kinzie J, et al: Induction chemotherapy in advanced head and neck cancer. A Radiation Therapy Oncology Group study. Arch Otolaryngol Head Neck Surg 113:193197, 1987
28. Kish JA, Ensley JF, Jacobs J, et al: A randomized trial of cisplatin (CACP) + Sfluorouracil (5FU) infusion and CACP + 5FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56:2740-2744, 1985
29. Al Kourainy K, Kish J, Ensley J, et al: Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 59:233-238, 1987
30. Kies M, Kraut M, Gordon L, et al: Improved survival and prelreatment characteristics of complete responders to combination chemotherapy in advanced head and neck cancer. Proc Am Soc Clin Oncol 2:626,160, 1983 (abstr)
31. Morris CM, Clark JR, Frei E, et al: Pathology of surgery after induction chemotherapy: An analysis of resectability and loco regioal control. Laryngoscope 96:292-302, 1986
32. Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
33. Demard F, Chauvel P, Santini J, et al: Response to chemother- apy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas. Head Neck 12:225-231, 1990
34. Karp DD, Vaughan CW, Carter R, et al: Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectoiny in advanced head and neck cancer. A long term follow-up report. Am J Clin Oncol 14:273-279, 1991
35. Vokes EE, Weichselbaum RR, Lippman SM, et al: Head and neck cancer. N Engl J Med 328:184-194, 1993
36. Shirinian MH, Weber RS, Lippman SM, et al: Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M.D. Anderson Cancer Center experience. Head Neck 16:39-44, 1994
37. Spaulding MB, Fisher ST, Wolf GT, et al: Tumor response, toxicity and survival after neo-adjuvant organ preserving chemotherapy in advanced laryngeal cancer. J Clin Oncol 12:1592-1599, 1994
38. Wolf GT, Hong WK: Induction therapy for organ preservation in advanced laryngeal cancer: Is there a role? Head Neck 12:279-283, 1995
39. Wolf GT, Makuch RW, Baker SR: Predictive factors for tumor response to preoperative chemotherapy in patients with head and neck squamous cell carcinoma. The head and neck contracts program. Cancer 54:2869-2877, 1984
40. Ayadi A, Bassot V, Donnadieu S, et al: Décés précoce après chimiothérapie dans les tumeurs des voies aréo-digestives supérieures. Ann Otolaryngol Chir Cervicofac 106:271-274, 1989